Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
HLA-B27 Status Shapes Axial Spondyloarthritis Phenotype
March 2026
An MRI-based cohort study shows HLA-B27–positive axial spondyloarthritis is linked to higher inflammation and distinct clinical features, with similar treatment use across groups.
Read more
31 Jul 2020
Is Tocilizumab Beneficial to Critically Ill COVID-19 Patients?
Tocilizumab, an immunosuppressant originally developed as a rheumatoid arthritis treatment, has demonstrated further benefits in treating patients…
5 May 2020
Initial Results of the COVID-19 Global Rheumatology Alliance Provider Registry
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of particular concern to patients who are immunocompromised…
5 May 2020
New Evidence Linking Gout and Risk of Heart Failure
GOUT has been linked to increased risk of incident heart failure in older adults according to a recent study by Dr Lisandro Colantonio and colleagues…
5 May 2020
Imaging Data Poses the Question: Is COVID-19 More Than a Lung Infection?
RAISED blood levels of D-dimer have been strongly associated with poor prognosis of coronavirus causing experts to investigate and provide guidance…
2 Apr 2020
Rheumatoid Arthritis Drug to be Repurposed for COVID-19 Therapy in Phase II/III Clinical Trial
The U.S. Department of Human Health and Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR)…
11 Feb 2020
Prevention of Fracture Risk with Supplementation Combination
DAILY supplementation with vitamin D and calcium showed great potential for reducing risk of fracture in a recent study…
11 Feb 2020
IL-4 and IL-13 Prevent Migration of Neutrophils to Inflammation Site
NOVEL drugs for the treatment of rheumatoid arthritis could earn a place in the medicine cabinet following the results of a study…
12 Nov 2019
Predicting Methotrexate Response in Rheumatoid Arthritis Patients
CHANGES in DNA methylation at 4 weeks of methotrexate treatment for rheumatoid arthritis (RA) were associated with improvements in symptoms at 6 months…
Loading posts...
« Previous
1
…
29
30
31
32
33
…
41
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View